![]() |
|
|
Vol. 30, Issue 10, 1070-1076, October 2002
Drug Metabolism and Drug Disposition Group (S.C.V., E.M.H., O.G.,
L.H.), University of Saskatchewan, and PharmaLytics (L.H.), Saskatoon,
Saskatchewan, Canada; and Drug Disposition and Metabolism Department,
AstraZeneca, Wilmington, DE (D.J.M.)
N-Glucuronidation at an aromatic tertiary amine of
5-membered polyaza ring systems was investigated for a model series of eight 1-substituted imidazoles in liver microsomes from five
species. The major objectives were to investigate substrate
specificities of the series in human microsomes and interspecies
variation for the prototype molecule, 1-phenylimidazole. The formed
quaternary ammonium-linked metabolites were characterized by positive
ion electrospray mass spectrometry. The incubation conditions for the
N-glucuronidation of 1-substituted imidazoles were
optimized; where for membrane disrupting agents, alamethicin was more
effective than the detergents examined. The need to optimize
alamethicin concentration was indicated by 4-fold interspecies
variation in optimal concentration and by a change in effect from
removal of glucuronidation latency to inhibition on increasing
concentration. For the four species with quantifiable
N-glucuronidation of 1-phenylimidazole, there were 8- and 18-fold variations in the determined apparent Km (range, 0.63 to 4.8 mM) and
Vmax (range, 0.08 to 1.4 nmol/min/mg of
protein) values, respectively. The apparent clearance values (Vmax/Km) were in
the following order: human
guinea pig
rabbit > rat
dog (no metabolite detected). Monophasic kinetics were observed for the
N-glucuronidation of seven substrates by human liver
microsomes, which suggests that one enzyme is involved in each
metabolic catalysis. No N-glucuronidation was observed
for the substrate containing the para-phenyl substituent
with the largest electron withdrawing effect,
1-(4-nitrophenyl)imidazole. Linear correlation analyses between
apparent microsomal kinetics and substrate physicochemical parameters
revealed significant correlations between Km
and lipophilicity (
para or log P values) and between
Vmax/Km and both
electronic properties (
para value) and pKa.
This article has been cited by other articles:
![]() |
Z. Yan, G. W. Caldwell, D. Gauthier, G. C. Leo, J. Mei, C. Y. Ho, W. J. Jones, J. A. Masucci, R. W. Tuman, R. A. Galemmo Jr., et al. N-GLUCURONIDATION OF THE PLATELET-DERIVED GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITOR 6,7-(DIMETHOXY-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-3-YL)-(3-FLUORO-PHENYL)-AMINE BY HUMAN UDP-GLUCURONOSYLTRANSFERASES Drug Metab. Dispos., May 1, 2006; 34(5): 748 - 755. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Alonen, O. Aitio, K. Hakala, L. Luukkanen, M. Finel, and R. Kostiainen BIOSYNTHESIS OF DOBUTAMINE MONOGLUCURONIDES AND GLUCURONIDATION OF DOBUTAMINE BY RECOMBINANT HUMAN UDP-GLUCURONOSYLTRANSFERASES Drug Metab. Dispos., May 1, 2005; 33(5): 657 - 663. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Soars, B. J. Ring, and S. A. Wrighton THE EFFECT OF INCUBATION CONDITIONS ON THE ENZYME KINETICS OF UDP-GLUCURONOSYLTRANSFERASES Drug Metab. Dispos., June 1, 2003; 31(6): 762 - 767. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Ghosheh and E. M. Hawes Microsomal N-Glucuronidation of Nicotine and Cotinine: Human Hepatic Interindividual, Human Intertissue, and Interspecies Hepatic Variation Drug Metab. Dispos., December 1, 2002; 30(12): 1478 - 1483. [Abstract] [Full Text] [PDF] |
||||